Abstract 11 — Development of a Novel Treg Activator KINE-101 for a New Treatment Option for Rheumatoid Arthritis
Background KINE-101, a novel synthetic nonapeptide, is being developed for the treatment of rheumatoid arthritis with a distinctive mode of action. A study using a collagen-induced arthritis (CIA) mouse model showed that KINE-101 suppressed cartilage damage through inhibiting osteoclastogenesis. KIN...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2023-11-01
|
Series: | Journal of Clinical Rheumatology and Immunology |
Online Access: | https://www.worldscientific.com/doi/10.1142/S2661341723740279 |